Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma

被引：3
|
作者：
Kuo, Alyce M. [1 ]
Hassoun, Hani [2 ]
Shah, Urvi [2 ]
Gordon, Allison [1 ]
Hollmann, Travis J. [3 ]
Landau, Heather J. [4 ]
Lezcano, Cecilia [3 ]
Mailankody, Sham [2 ]
Tan, Carlyn C. [2 ]
Lesokhin, Alexander M. [2 ]
Markova, Alina [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Dermatol Serv, 545 E 73rd St, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, Dermatopathol Serv, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY USA
来源：
LEUKEMIA & LYMPHOMA | 2022年 / 63卷 / 09期
关键词：
CELLS; SKIN;
D O I：
10.1080/10428194.2022.2068002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2233 / 2237
页数：5
相关论文
共 50 条
  • [21] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
    Siegel, D. S.
    Richardson, P.
    Dimopoulos, M.
    Moreau, P.
    Mitsiades, C.
    Weber, D.
    Houp, J.
    Gause, C.
    Vuocolo, S.
    Eid, J.
    Graef, T.
    Anderson, K. C.
    BLOOD CANCER JOURNAL, 2014, 4 : e182 - e182
  • [22] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
    D S Siegel
    P Richardson
    M Dimopoulos
    P Moreau
    C Mitsiades
    D Weber
    J Houp
    C Gause
    S Vuocolo
    J Eid
    T Graef
    K C Anderson
    Blood Cancer Journal, 2014, 4 : e182 - e182
  • [23] Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma
    Nikhil C Munshi
    Constantine Mitsiades
    Paul G Richardson
    Kenneth C Anderson
    Nature Clinical Practice Oncology, 2008, 5 : 374 - 375
  • [24] CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN JAPANESE PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Ri, M.
    Suzuki, K.
    Chou, T.
    Sugiura, I.
    Takezako, N.
    Sunami, K.
    Ishida, T.
    Izumi, T.
    Ozaki, S.
    Iida, S.
    HAEMATOLOGICA, 2016, 101 : 787 - 788
  • [25] How lenalidomide is changing the treatment of patients with multiple myeloma
    Dimopoulos, Meletios A.
    Terpos, Evangelos
    Niesvizky, Ruben
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 88 : S23 - S35
  • [26] Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma
    Munshi, Nikhil C.
    Mitsiades, Constantine
    Richardson, Paul G.
    Anderson, Kenneth C.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (07): : 374 - 375
  • [27] Repeated Lenalidomide Treatment in Patients With Relapsed Multiple Myeloma
    Stork, Martin
    Pour, Ludek
    Adam, Zdenek
    Krejci, Marta
    Sandecka, Viera
    Vaculova, Jitka
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E56 - E57
  • [28] Analysis of risk factors for lenalidomide-associated skin rash in patients with multiple myeloma
    Sugi, Tomiyuki
    Nishigami, Yasuo
    Saigo, Hirohisa
    Hanai, Homare
    Takabatake, Keisuke
    Mita, Mitsuo
    Ohara, Shin
    Ide, Shiro
    Uchida, Tomoyuki
    Inoue, Morihiro
    Hagihara, Masao
    LEUKEMIA & LYMPHOMA, 2021, 62 (06) : 1405 - 1410
  • [29] Multiple Myeloma Patients with Lenalidomide-Associated Skin Rash Have a Favorable Prognosis
    Kojima, Ayumi
    Tanaka, Yuka
    Kimura, Yuta
    Tsuchimoto, Daisuke
    Etani, Rina
    Kanematsu, Tetsufumi
    Miyazawa, Kenji
    Mori, Akiya
    Naruse, Atsuhiko
    Nagai, Hirokazu
    BLOOD, 2016, 128 (22)
  • [30] Vorinostat in Combination With Lenalidomide and Dexamethasone in Lenalidomide-Refractory Multiple Myeloma
    Bilotti, Elizabeth
    Vesole, David H.
    McBride, Laura
    Schmidt, Linda
    Gao, Zhijie
    Gilani, Madiha
    McNeill, Ann
    Bednarz, Urszula
    Richter, Joshua
    Mato, Anthony
    Graef, Thorsten
    Siegel, David S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (10): : 558 - 562
12345